Low cost production of rabies virus antigens in rice grain
Low cost production of rabies virus antigens in rice grain
批准号:
8122711
负责人:
NING HUANG
金额:
$22.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-20 至 2013-05-31
关键词:
AccountingAddressAgricultureAnimalsAntibodiesAntigensBaculovirus Expression SystemBindingBiochemicalCanis familiarisCase StudyCenters for Disease Control and Prevention (U.S.)CerealsCessation of lifeCharacteristicsCholera Toxin Protomer BCodeCommunicable DiseasesDisease ReservoirsDoseEconomic BurdenEnvironmentEpitopesFeasibility StudiesGTP-Binding ProteinsGenesGlycoproteinsHumanImmune responseImmunityImmunizationInfectionInjection of therapeutic agentIntramuscularInvestigationIsoelectric PointLicensingLivestockMephitidaeMolecular WeightMusMutateN-terminalOralOral AdministrationPhasePlantsPlasmidsPreventionPrevention programProcessProductionPublic HealthRabiesRabies VaccinesRabies virusRaccoonsRecombinant ProteinsRecombinantsReportingRiceSafetyScientistSeedsSmall Business Innovation Research GrantSymptomsSystemTechnologyTestingTimeTransgenic OrganismsUnited StatesVaccinatedVaccinationVaccine AntigenVaccinesVacciniaVaccinia virusVacciniumViralViral AntigensVirusWild Animalsbasecostcost effectivenessdisorder preventionfeedingimmunogenicimmunogenicitymeetingsmouse modelmutantnovelpet animalpreventprogramsprotein expressionrabies virus glycoprotein Gresearch studyscale up
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Rabies is the 10th most lethal infectious diseases in the world, causing approximately 60,000 deaths annually. Rabies is invariably fatal once symptoms occur. Prevention is the key in rabies control. In the US, rabies remains a significant wildlife- management and public-health challenge. The Centers for Disease Control and Prevention (CDC) report that over 90% of rabies cases in the United States are caused by wildlife. The economic burden of rabies in the US exceeds $300 million per year. Oral vaccination is the only effective way to control rabies in wildlife. The only licensed vaccinia-based oral rabies vaccine has cost-effectiveness and safety concerns. There is a need for safer and less expensive oral rabies vaccine both domestically and internationally. Here we propose to develop an oral rabies vaccine in rice grain using our proprietary protein expression technology. We think favorable safety profile, low production costs and high level expression of antigen of our expression system will make a safer vaccine at an affordable cost. In the present SBIR feasibility study, Ventria Bioscience and CDC will collaborate to develop four recombinant plasmid constructs of rabies virus glycoprotein genes. Using the constructed genes, we will develop transgenic rice plants to obtain transgenic seeds. After confirmed by viral glycoprotein expression analysis, devitalized transgenic rice grain will be fed in a mouse model to test oral immune responses and its protection in rabies challenge. We expect at least 1 of the 4 transgenic rice lines will generate at least 80% of protection in the mouse model.
PUBLIC HEALTH RELEVANCE: Current oral rabies vaccine has limitation of both safety concern and high cost. We propose to produce the vaccine in rice grain which is safe and can be produced economically. The vaccine, upon meeting all production, quality, and regulatory requirements, would be used in baits for state and federal rabies prevention programs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Low-cost production of rApoA-IM for the treatment of cardiovascular disease
-
批准号:8709796
-
项目类别:
-
资助金额:$26.09万
-
财政年份:2014
-
负责人:NING HUANG
-
依托单位:
Production of human MUC17 (CRD1-L-CRD2) recombinant protein in rice for the treat
-
批准号:8451917
-
项目类别:
-
资助金额:$23.73万
-
财政年份:2013
-
负责人:NING HUANG
-
依托单位:
Lactoferrin for the prevention of antibiotic-associated diarrhea in adult
-
批准号:8323230
-
项目类别:
-
资助金额:$42.08万
-
财政年份:2010
-
负责人:NING HUANG
-
依托单位:
Lactoferrin for the prevention of antibiotic-associated diarrhea in adult
-
批准号:7910041
-
项目类别:
-
资助金额:$53.83万
-
财政年份:2010
-
负责人:NING HUANG
-
依托单位:
Lactoferrin for the prevention of antibiotic-associated diarrhea in adult
-
批准号:8305862
-
项目类别:
-
资助金额:$41.32万
-
财政年份:2010
-
负责人:NING HUANG
-
依托单位:
Production of OspA in rice for the control of Lyme Disease
-
批准号:7611034
-
项目类别:
-
资助金额:$12.65万
-
财政年份:2009
-
负责人:NING HUANG
-
依托单位:
Production of OspA in rice for the control of Lyme disease
-
批准号:8101241
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2009
-
负责人:NING HUANG
-
依托单位:
Production of OspA in rice for the control of Lyme disease
-
批准号:8296677
-
项目类别:
-
资助金额:$28.66万
-
财政年份:2009
-
负责人:NING HUANG
-
依托单位:
Production of OspA in rice for the control of Lyme disease
-
批准号:7999336
-
项目类别:
-
资助金额:$45.52万
-
财政年份:2009
-
负责人:NING HUANG
-
依托单位:
Recombinant Human Serum Albumin for Use in Cell Culture
-
批准号:7779390
-
项目类别:
-
资助金额:$37.79万
-
财政年份:2007
-
负责人:NING HUANG
-
依托单位:
Recombinant human serum albumin for use in cell culture media
-
批准号:7218792
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2007
-
负责人:NING HUANG
-
依托单位:
Use of recombinant human lactoferrin for wounds by stimulating cell growth
-
批准号:7159482
-
项目类别:
-
资助金额:$11.39万
-
财政年份:2006
-
负责人:NING HUANG
-
依托单位:
Recombinant human serum albumin for therapeutic use
-
批准号:7051561
-
项目类别:
-
资助金额:$9.95万
-
财政年份:2006
-
负责人:NING HUANG
-
依托单位:
Recombinant human defensin for management of ileal Crohn's disease
-
批准号:7106842
-
项目类别:
-
资助金额:$18.93万
-
财政年份:2006
-
负责人:NING HUANG
-
依托单位:
Lactoferrin prevents biofilm formation at wound
-
批准号:6933304
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2005
-
负责人:NING HUANG
-
依托单位:
THERAPEUTICS OF HUMAN PROTEINS PRODUCED IN PLANTS
-
批准号:2539057
-
项目类别:
-
资助金额:$9.42万
-
财政年份:1998
-
负责人:NING HUANG
-
依托单位:
海外基金